Patent Opposition Database

Hide annotations

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): P000103667 divisional of P990103342
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Opposition status: Unknown
Date: 09-09-2002
Patent type: Formulations

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

10 similar patent oppositions

CILFA opposition, carvedilol+hydrochlorothiazide, (P990105974)

Countries: Argentina Date: 2002
CILFA opposition, Nadifloxacin, (P990106490)

Countries: Argentina Date: 2002
CILFA opposition, fexofenadine+cyclodextrins, (P990105185)

Countries: Argentina Date: 2002
CILFA opposition, descarboetoxiloratadina + fosfatodibásico de calcio, (P000103668 divisional of P990103342)

Countries: Argentina Date: 2002
CILFA opposition, Gamma-aminobutiric acid derivatives including gabapentin , pregabalin, baclofen, (P990102313)

Countries: Argentina Date: 2002
CILFA opposition, cetirizine, (P990104039)

Countries: Argentina Date: 2002
CILFA opposition, reverastrol + L-carnitine, (P990105115)

Countries: Argentina Date: 2002
CILFA opposition, neurokinin antagonist/H1 antagonist/H2 antagonists, (P990105080)

Countries: Argentina Date: 2002
CILFA opposition, rosuvastatin, (P000100408)

Countries: Argentina Date: 2002
CILFA opposition, rosuvastatin, (P000104057)

Countries: Argentina Date: 2002